Experimental pathogenicity of four opportunist Fusarium species in a murine model

Journal of Medical Microbiology

Volumn 48, Issue 4, 1999, Pages 363-366

  Mayayo, E ^a   Pujol, I ^b   Guarro, J ^c  

^a HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

^b HOSPITAL UNIVERSITARI SANT JOAN DE REUS   (Spain)

^c FACULTAT DE MEDICINA I CIÈNCIES DE LA SALUT   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPARATIVE STUDY; FUSARIUM; FUSARIUM OXYSPORUM; FUSARIUM PROLIFERATUM; FUSARIUM SOLANI; HEART DISEASE; IMMUNOCOMPETENCE; KIDNEY INFECTION; MALE; MOUSE; MYCOSIS; NONHUMAN; OPPORTUNISTIC INFECTION; PATHOGENICITY; PRIORITY JOURNAL; RISK; TAIL; VEIN; VIRULENCE;

EID: 0032859607     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/00222615-48-4-363     Document Type: Article

References (18)

1. Guarro J, de Hoog GS, Figueras MJ, Gené J. Rare opportunistic fungi. In: de Hoog GS, Guarro J (eds) Atlas of clinical fungi. Baarn, Centraalbureau voor Schimmelcultures. 1995: 241-675.
2. Guarro J, Gené J. Opportunistic fusarial infections in humans. Eur J Clin Microbiol Infect Dis 1995; 14: 741-754.
3. Legrand C, Anaissie E, Hashem R, Nelson P, Bodey GP, Ro J. Experimental fusarial hyalohyphomycosis in a murine model. J Infect Dis. 1991; 164: 944-948.
4. Anaissie EJ, Hachem R, Legrand C, Legenne P, Nelson P, Bodey GP. Lack of activity of amphotericin B in systemic murine fusarial infection. J infect Dis 1992; 165: 1155-1157.
5. Pujol I, Guarro J, Gené J, Sala J. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother 1997; 39: 163-167.
6. Barrios NJ, Kirkpatrick DV, Murciano A, Stine K, Van Dyke RB, Humbert JR. Successful treatment of disseminated Fusarium infection in an immunocompromised child. Am J Pediatr Hematol Oncol 1990; 12: 319-324.
7. Raad I, Hachem R. Treatment of central venous catheter-related fungemia due to Fusarium oxysporum. Clin Infect Dis 1995; 20: 709-711.
8. Eljaschewitsch J, Sandfort J, Tintelnot K, Horbach I, Ruf B. Port-a-cath-related Fusarium oxysporum infection in an HIV-infected patient: treatment with liposomal amphotericin B. Mycoses 1996; 39: 115-119.
9. Cano J, Mayayo E, Guarro J. Experimental pathogenicity of Aphanoascus spp. Mycoses 1990; 33: 41-45.
10. Cano J, Guarro J, Mayayo E, Fernández-Ballart J. Experimental infection with Scedosporium inflation. J Med Vet Mycol 1992; 30: 413-420.
11. Foster CS. Fungal keratitis. Infect Dis Clin North Am 1992; 6: 851-857.
12. Licsegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. Am J Ophthalmol 1980; 90: 38-47.
13. Forster RK, Rebell G. The diagnosis and management of keratomycosis, I. Cause and diagnosis. Arch Ophthalmol 1975; 93: 975-978.
14. Gugnani HC, Talwar RS, Njsoku-Obi ANV, Kodilinye HC. Mycotic keratitis in Nigeria. A study of 21 cases. Br J Ophthalmol 1976; 60: 607-613.
15. Ishibashi Y, [Keratomycosis in Japan reported from 1976 to 1980.] Nippon Ganka Gakkai Zasshi 1982; 86: 651-656.
16. Jones DB, Sexton RR, Rebell G. Mycotic keratitis in south Florida, a review of 39 cases. Trans Ophthalmol Soc UK 1969; 89: 781-797.
17. Polack FM, Kaufman HE, Newmark E. Keratomycosis. Medical and surgical treatment. Arch Opthalmol 1971; 85: 410-416.
18. Strelow SA, Kent HD, Eagle RC, Cohen EJ. A case of contact lens related Fusarium solani keratitis. CLA Op J 1992; 18: 125-127.